Kö'ln, Germany

Frank Volz

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Cologne, DE (2015 - 2018)
  • Köln, DE (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovations and Patents of Frank Volz in Pharmaceutical Chemistry

Introduction

Frank Volz is an accomplished inventor based in Köln, Germany, renowned for his significant contributions to the field of pharmaceutical chemistry. With a portfolio of 15 patents, he has made notable advancements in chemical processes related to the synthesis of various compounds.

Latest Patents

Among Volz's recent innovations are pivotal patents focused on the catalytic hydrogenation of substituted cyanopyridines and a method for preparing 5-fluoro-1H-pyrazole-4-carbonyl fluorides. The first patent pertains to novel processes for producing substituted pyridyl-methylbenzamide derivatives, particularly 2,6-dichloro-N-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methyl}benzamide, known as Fluopicolide. Additionally, this invention relates to the catalytic hydrogenation of substituted cyanopyridine derivatives, transforming them into corresponding substituted 2-methylaminopyridine derivatives in the presence of specific metal catalysts, such as palladium.

The second patent outlines a novel approach for synthesizing 5-fluoro-1H-pyrazole-4-carbonyl fluorides, achieved through a halogen exchange reaction of 5-chloro-1H-pyrazole-4-carbonyl chlorides with alkali metal fluorides, utilizing non-polar solvents for this chemical transformation.

Career Highlights

Frank Volz has had a distinguished career, with significant tenures at Bayer CropScience AG and Bayer Intellectual Property GmbH. His work with these prestigious organizations has allowed him to engage in groundbreaking research and innovation in pharmaceutical sciences.

Collaborations

Throughout his career, Volz has collaborated with esteemed colleagues such as Sergii Pazenok and Thomas Himmler. These partnerships have fostered a dynamic exchange of ideas and have led to the development of innovative chemical solutions that enhance their respective fields.

Conclusion

Frank Volz stands out as a prominent figure in the realm of pharmaceutical innovation. His dedicated research, evidenced by his multiple patents, showcases his commitment to advancing chemical processes. As he continues to innovate, Volz remains a key contributor to the evolving landscape of pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…